This HTML5 document contains 148 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n11http://dx.doi.org/10.2147/

Statements

Subject Item
wd:Q38641431
rdf:type
wikibase:Item
schema:description
2017年论文 scientific article published on 28 July 2017 مقالة علمية نشرت في 28 يوليو 2017 tieteellinen artikkeli 2017年の論文 2017年论文 artigo científico articol științific vědecký článek artikel ilmiah vitenskapelig artikkel wetenschappelijk artikel 2017年論文 บทความทางวิทยาศาสตร์ 2017年论文 artikull shkencor teaduslik artikkel vedecký článok научни чланак artykuł naukowy scientific article published on 28 July 2017 vetenskaplig artikel artigo científico article scientifique scientific article published on 28 July 2017 2017年論文 2017年论文 article científic vitskapeleg artikkel বৈজ্ঞানিক নিবন্ধ scienca artikolo 2017年論文 επιστημονικό άρθρο article scientific מאמר מדעי bài báo khoa học 2017年論文 bilimsel makale научна статия 2017년 논문 artikulong pang-agham articolo scientifico naučni članak artículo científico наукова стаття, опублікована в липні 2017 2017 nî lūn-bûn 2017年论文 tudományos cikk научни чланак artículu científicu espublizáu en 2017 2017年论文 wissenschaftlicher Artikel videnskabelig artikel სამეცნიერო სტატია artigo científico научная статья мақолаи илмӣ 2017年論文
p:P577
wds:Q38641431-4E19B96C-F196-49A6-AB53-E8DB666D20BD
wdt:P577
2017-07-28T00:00:00Z
p:P407
wds:Q38641431-9E59762E-F531-45A2-91C8-188A62BA7182
wdt:P407
wd:Q1860
p:P2860
wds:Q38641431-06C9A502-A2A0-4A31-B745-81B76435A6DE wds:Q38641431-12262A72-312A-4AD6-ADEF-364AA2DD30BE wds:Q38641431-8A71C86C-23C3-45B8-A53C-D898E78559E8 wds:Q38641431-9EA3CD92-6E2C-42DE-9E69-4EAA31B5058B wds:Q38641431-B6DB642D-87F4-4B58-93AE-10C1897E0101 wds:Q38641431-E20E2664-2E92-46DD-B98F-37CBCBB2A6C0 wds:Q38641431-19CD5E1E-712A-488F-9A74-A42660388EAE wds:Q38641431-262C7EB5-CABC-4A44-A297-150B29C4D182 wds:Q38641431-3E746D0B-ECB8-49A4-AADC-BCB4ABB8AD28 wds:Q38641431-4B2389FB-C1DD-43C6-9DC4-BB7500C6976F wds:Q38641431-4E48C782-7AE8-4FB0-94F3-B1CE00A31E86 wds:Q38641431-62909CDA-E567-4E38-8CB2-F5D8A1F1D5E2 wds:Q38641431-6E4FF62F-4E08-4B9F-A5D9-27968824C6D9 wds:Q38641431-716780DD-EEB1-4E99-AEBA-AE3682CA38BD wds:Q38641431-78974BD3-671A-40F3-A67B-02429E2E7041 wds:Q38641431-7A257C64-3D43-43BA-A10B-C3A11D2E970B wds:Q38641431-8233DB6E-D7BC-49B4-8CA5-9116BA41D441 wds:Q38641431-F04A8F2F-1001-4300-AF0D-EF7F583A6BFF wds:Q38641431-F6755448-F620-435D-85F9-A9B37ED30FBD
wdt:P2860
wd:Q47856931 wd:Q35048301 wd:Q26852081 wd:Q46554870 wd:Q46048883 wd:Q46131525 wd:Q80330544 wd:Q46053077 wd:Q37744195 wd:Q35113679 wd:Q37690027 wd:Q83942416 wd:Q46319213 wd:Q42683340 wd:Q36812580 wd:Q50714335 wd:Q38476881 wd:Q74452012 wd:Q69667742
p:P2093
wds:Q38641431-6639A2AB-E612-4D08-820E-009D34CCDD32 wds:Q38641431-524D68CF-617A-4FE2-8495-107A47830B9F wds:Q38641431-AD9049DC-2C6A-427F-9ED2-36C4AC413E34 wds:Q38641431-9275B938-5FDC-43AE-A47D-4C889AFF899F
wdt:P2093
Varun Ektare Mei Xue Yanjun Bao Vishvas Garg
rdfs:label
Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients
skos:prefLabel
Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients
schema:name
Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients
p:P50
wds:Q38641431-A7289157-6250-4BCB-91DB-E4A911F68033 wds:Q38641431-94D850D1-CAF7-4974-A186-241655517CC8
wdt:P50
wd:Q118489410 wd:Q92095812
p:P1476
wds:Q38641431-D0AD369B-A3FC-45A1-9998-32EED4069CD2
wdt:P1476
Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients
p:P304
wds:Q38641431-E72E108E-2AB9-4BA2-83F4-5909A53CEF01
wdt:P304
451-458
p:P31
wds:Q38641431-907C0DFF-DED0-4E98-B2D5-F85806CA5905
wdt:P31
wd:Q13442814
p:P921
wds:Q38641431-4B3E3CAD-E6DA-4F8F-8A53-DDF7E5D3E12E
wdt:P921
wd:Q187255
p:P698
wds:Q38641431-CD041D7C-47B5-430B-8DE5-6715E6CA79BC
wdtn:P698
n10:28814890
wdt:P698
28814890
p:P1433
wds:Q38641431-C4C958D4-AB82-4386-A1D0-19E6DA3E05CF
wdt:P1433
wd:Q5133862
p:P478
wds:Q38641431-38137024-FE50-4ECB-A5B4-B1D22FFCF4D9
wdt:P478
9
p:P356
wds:Q38641431-CD226FD2-FE39-4684-B0B8-9D5A17093872
wdtn:P356
n11:CEOR.S136327
wdt:P356
10.2147/CEOR.S136327
p:P275
wds:Q38641431-d341815d-faa9-49a1-99c5-b79275c65af3
p:P6216
wds:Q38641431-ffd98969-0386-46c0-bd33-a7287e17681e
wdt:P275
wd:Q18810331
wdt:P6216
wd:Q50423863
p:P8608
wds:Q38641431-EBEB770D-D420-4909-9505-64273C6B4640
wdt:P8608
release_ydvarxfeaveqvmoeorr5nkll7a
p:P932
wds:Q38641431-EE6B80D4-BC2C-42E6-9C3D-C6520D6E04F0
wdt:P932
5546181